NCT04170114 Comparison of the Efficacy of Comprehensive Respiratory Physiotherapy in Children With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis Status COMPLETED Phase NA
NCT04153448 Comparison of Sit-to-stand Test With Six-minute Walk Test in Bronchiectasis and Healthy Children Status COMPLETED Phase N/A
NCT04140214 Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR) Status COMPLETED Phase PHASE3
NCT04122547 Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis Status COMPLETED Phase PHASE3
NCT04090294 Assessment of Early Outcomes of Roflumilast in Patients With Non Cystic Fibrosis Bronchiectasis Status UNKNOWN Phase EARLY_PHASE1
NCT04081740 Biological Determinants of Sputum Rheology in Chronic Airway Diseases Status COMPLETED Phase N/A
NCT04038892 The Effect of Different Virtual Reality-Based Exercise Trainings on Pulmonary Function, Respiratory and Peripheral Muscle Strength, Functional Capacity and Balance in Children With Bronchiectasis Status COMPLETED Phase NA
NCT04017312 A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting Status TERMINATED Phase NA
NCT03966066 Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention Status UNKNOWN Phase NA
NCT03950531 The Effect of Bronchiectasis on the Exacerbation and Mortality in COPD Status COMPLETED Phase N/A
NCT03903913 Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis Status UNKNOWN Phase PHASE2
NCT03902236 Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis Status UNKNOWN Phase N/A
NCT03846570 Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial Status TERMINATED Phase PHASE3
NCT03745196 The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory Diseases Status TERMINATED Phase PHASE2
NCT03737617 Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis Status WITHDRAWN Phase PHASE4